Michaela Riedl

Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial

George J. Kahaly, Michaela Riedl, J. König et al. · The Lancet Diabetes & Endocrinology · 2018 · 212 citations

Methylprednisolone Versus Methylprednisolone, Endocrine Disease, Medicine +5

The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese Patients

Greisa Vila, Michaela Riedl, Christian Anderwald et al. · Clinical Chemistry · 2010 · 179 citations · Full text

Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men

Martin Clodi, Greisa Vila, René Geyeregger et al. · American Journal of Physiology-Endocrinology and Metabolism · 2008 · 170 citations

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 169 citations · Full text

Late-onset Pompe Disease, Autoimmune Disease, Clinical Infectious Disease +3

Feasibility of a Mobile Phone–Based Data Service for Functional Insulin Treatment of Type 1 Diabetes Mellitus Patients

A. Kollmann, Michaela Riedl, Peter Kästner et al. · Journal of Medical Internet Research · 2007 · 152 citations · Full text